Nature biotechnology

AI-driven improvements to lab-evolved enzymes boost prime editing

Updated

Abstract

Essence

AI-guided redesign of prime editor reverse transcriptases improved stability, expression, and prime editing efficiency across ex vivo systems and in mice.

Evidence

Protein-engineering and preclinical genome-editing study redesigning reverse transcriptase domains with structure-informed AI, then testing edited constructs in human primary cells, multiple delivery modalities, and mice.

Caveat

This is platform and preclinical evidence, so stronger editing performance does not by itself establish therapeutic safety or effectiveness in humans.

Simplified

Full Text

Full text is available at the source.

what lands in your inbox each week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free